The firm founded by Andrew Left, which was central in unraveling allegations of fraud at Valeant Pharmaceuticals, tweeted that shareholders are discounting six risks for Nvidia in 2017.
ADVERTISEMENT
Short-seller Andrew Left has a new target (NVDA, INTC)
Citron Research has a new target for the new year: Nvidia Corporation.
ADVERTISEMENT
Recommended articles
"Citron readers know we have long been fans of $NVDA, but now the market is disregarding headwinds," Citron tweeted.
Shares of Nvidia, which makes processors for video games, fell by as much as 3% on Wednesday after the tweet.
In brief, Citron said:
ADVERTISEMENT
Nvidia is the best performer on the S&P 500 this year and is up 245% year-to-date after Wednesday's pullback. Citron said it sees the stock heading back to $90 per share, down about 21% from current levels.
Citron readers know we have... @ Citron Research
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT